ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,483Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 1456

$1.14M Total Retail Price of All Prescriptions

Rank: 82 out of 1456

607 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 607 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

26% of this provider’s 607 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 19,907 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 1,404 1,222 1 1
HYDROCODONE-ACETAMINOPHEN 979 730 S3 2 6
FUROSEMIDE 827 716 3 7
POTASSIUM CHLORIDE 767 711 4 15
OMEPRAZOLE 646 570 5 5
LISINOPRIL 623 505 6 3
SIMVASTATIN 597 479 7 2
METFORMIN HCL 528 418 8 8
LEVOTHYROXINE SODIUM 526 471 9 4
CRESTOR 373 280 10 26
PRAVASTATIN SODIUM 369 306 11 9
METHYLPREDNISOLONE 359 276 12 106
METOPROLOL TARTRATE 346 286 13 12
CARVEDILOL 330 303 14 20
FAMOTIDINE 327 271 15 45
GABAPENTIN 308 230 16 13
SERTRALINE HCL 300 290 17 25
HYDROCHLOROTHIAZIDE 297 269 18 10
WARFARIN SODIUM 282 225 19 21
ATORVASTATIN CALCIUM 261 235 20 11
GLIPIZIDE ER 247 228 21 86
AZITHROMYCIN 246 188 22 44
LOVASTATIN 242 178 23 40
TRAMADOL HCL-ACETAMINOPHEN 236 214 24 139
TRAZODONE HCL 224 161 25 47
DIOVAN 219 181 26 35
METOPROLOL SUCCINATE 210 199 27 19
DIGOXIN 206 190 28 62
FENTANYL 201 175 S2 29 114
ALLOPURINOL 194 181 30 31
LOSARTAN POTASSIUM 185 169 31 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 163 32 24
MIRTAZAPINE 179 178 33 65
DONEPEZIL HCL 177 177 34 29
RANITIDINE HCL 174 145 35 27
ISOSORBIDE MONONITRATE ER 170 157 36 60
NOVOLOG MIX 70-30 166 123 37 204
NEXIUM 162 89 38 23
RISPERIDONE 158 110 39 72
ZOLPIDEM TARTRATE 158 93 39 14
TRIAMTERENE-HCTZ 154 85 41 49
INSULIN SYRINGE 150 107 42 64
PANTOPRAZOLE SODIUM 145 120 43 43
NAMENDA 141 141 44 38
POLYETHYLENE GLYCOL 3350 138 128 45 85
ATENOLOL 137 121 46 18
TRAMADOL HCL 137 96 46 17
SPIRONOLACTONE 135 101 48 73
PAROXETINE HCL 133 64 49 67
COMBIVENT 130 87 50 110
LOSARTAN-HYDROCHLOROTHIAZIDE 126 102 51 41
DIOVAN HCT 124 107 52 59
CLOPIDOGREL 124 120 52 32
CLONIDINE HCL 121 76 54 39
VENLAFAXINE HCL ER 119 103 55 89
CITALOPRAM HBR 118 88 56 22
KLOR-CON M20 115 71 57 51
NOVOLIN 70-30 112 111 58 144
ADVAIR DISKUS 111 106 59 63
TAMSULOSIN HCL 110 101 60 34
CIPROFLOXACIN HCL 109 88 61 58
OXYCODONE-ACETAMINOPHEN 109 81 S2 61 109
PROAIR HFA 104 71 63 69
GLIPIZIDE 104 75 63 53
PLAVIX 103 97 65 46
PHENYTOIN SODIUM EXTENDED 103 39 65 128
KLOR-CON 10 101 64 67 96
HYDRALAZINE HCL 100 86 68 48
ESCITALOPRAM OXALATE 100 92 68 74
FELODIPINE ER 99 76 70 150
MELOXICAM 98 67 71 30
AMITRIPTYLINE HCL 97 83 R 72 70
QUETIAPINE FUMARATE 93 73 73 78
CELEBREX 91 91 74 88
JANUVIA 89 89 75 68
CARISOPRODOL 87 0 R 76 80
CYCLOBENZAPRINE HCL 84 56 R 77 66
METFORMIN HCL ER 80 51 78 54
LYRICA 80 58 78 91
DILTIAZEM ER 79 36 80 147
ALENDRONATE SODIUM 78 69 81 36
AMLODIPINE BESYLATE-BENAZEPRIL 77 63 82 61
TORSEMIDE 76 73 83 145
FLUTICASONE PROPIONATE 76 48 83 28
LANSOPRAZOLE 74 60 85 137
TOPIRAMATE 71 26 86 196
SPIRIVA 70 52 87 75
OXYCODONE HCL-ACETAMINOPHEN 70 49 S2 87 132
GLIMEPIRIDE 69 57 89 33
LIPITOR 66 49 90 76
DILTIAZEM 24HR CD 65 65 91 159
PREDNISONE 65 60 91 42
AVODART 65 65 91 218
SEROQUEL 64 42 94 154
DETROL LA 62 37 95 213
EXELON 62 62 95 105
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 47 97 107
ALBUTEROL SULFATE 59 50 98 136
TRICOR 59 40 98 92
METOCLOPRAMIDE HCL 57 57 100 125
OXYBUTYNIN CHLORIDE 57 36 100 156
NIFEDIPINE ER 56 47 102 81
SEROQUEL XR 55 30 103 317
MECLIZINE HCL 55 42 103 101
AMOXICILLIN 55 47 103 112
LEVOFLOXACIN 53 43 106 79
LEXAPRO 53 47 106 206
FLUOXETINE HCL 52 45 108 55
PROMETHAZINE HCL 51 34 R 109 77
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.